Abstract:1112 Objectives: GluN2B is the most studied subunit of N‑methyl‑D‑aspartate receptors (NMDARs), which are related to the pathologies of various central nervous system disorders and neurodegenerative diseases, such as Parkinson’s disease (PD), Alzheimer’s disease (AD), Schizophrenia and neuropathic pain [1]. However, the in vivo imaging of GluN2B subunit remains a challenge. Herein we attempt to develop novel probes for positron emission computed tomography (PET) imaging of the GluN2B subunit. Methods: The synthesis of cold compound 5, 2-(6-(4-fluoro-3-methylphenyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-N,N-dimethylacetamide, was achieved following a 3-step process [2]. The amidation of starting material 2-bromo-acetic acid 1 with methylamine in THF solution afforded the 2-bromo-N,N-dimethylacetamide 2. A SN2 reaction between amide 2 and 6-bromo-1H-pyrrolo[3,2-b]pyridine 3 in the presence of K2CO3 in DMF gave 2-(6-bromo-1H-pyrrolo[3,2-b]pyridin-1-yl)-N,N-dimethylacetamide 4 with a yield of 81%. Then Pd(dppf)Cl2-catalyzed cross-coupling between amide 4 and (4-fluoro-3-methylphenyl)boronic acid provided the title product. By following the same method, 11C-labeling precursor, 2-(6-(4-fluoro-3-methylphenyl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-N-methylacetamide 8, was obtained by replacing methylamine in THF solution with H2NMe·HCl. Radiosynthesis of [11C]5 was obtianed using [11C]CH3I with K2CO3 in DMSO at 130 oC from precursor 8. The brain uptake studies were conducted in mice after 1, 2, and 5 min post-injection. Results: The cold compound 5 was obtained in total yield of 21% over 3 steps, and the corresponding precursor 8 was achieved in 18%. The biological assay of compound 5 in trifluoroacetate salt form has been reported with pIC50 = 6.3 ([3H] inhibition binding assay) [2].11C-methylation strategy delivered the tracer [11C]5 in 4% isolated radiochemical yield (non-decay corrected from [11C]CO2) with high radiochemical purity (>99%) and high specific activity of 17.7 GBq/μmol. The brain uptake study revealed that [11C]5 exhibited moderate standard uptake valves (SUVs) in mice brain with the values of 0.61, 0.55 and 0.50 at 1, 2, and 5 min post-injection, respectively. Conclusions: We have successfully synthesized and radiolabeled a potent GluN2B-selective NMDA receptor antagonist [11C]5, which showed moderate brain uptake in mice brain. Further studies including radiolabeling of the analogous, blocking studies, ex in vivo biodistribution, and dynamic PET scan are on the way. References: [1] Cur Top Med. Chem. 2016, 16, 1830-1842; [2] US2018208595, 2018.

Novel Pyridyl Ring C5 Substituted Analogues Of 3-(1-Methyl-2(S)- Pyrrolidinylmethoxy)Pyridine (A-84543) As Highly Selective Agents For Neuronal Nicotinic Acetylcholine Receptor(Nachr)

Design and Synthesis of New Agents for Neuronal Nicotinic Acetylcholine Receptor (nachrs) Imaging.

Synthesis and Structure–activity Relationships of 5-Substituted Pyridine Analogues of 3-[2-((s)-pyrrolidinyl)methoxy]pyridine, A-84543: A Potent Nicotinic Receptor Ligand

[ 125/123 I] 5-Iodo-3-pyridyl Ethers

Synthesis And Structure-Activity Relationships Of Pyridine-Modified Analogs Of 3-[2-((S)-Pyrrolidinyl)Methoxy]Pyridine, A-84543, A Potent Nicotinic Acetylcholine Receptor Agonist

Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.

Design, Synthesis and Biological Evaluation of 1,4-Diazobicylco[3.2.2]nonane Derivatives As Α7-Nicotinic Acetylcholine Receptor PET/CT Imaging Agents and Agonists for Alzheimer's Disease.

Chemistry And Pharmacological Characterization Of Novel Nitrogen Analogues Of Amop-H-Oh (Sazetidine-A, 6[5-(Azetidin-2-Ylmethoxy)Pyridin-3-Yl]Hex-5-Yn-L-Ol) As Alpha 4 Beta 2-Nicotinic Acetylcholine Receptor-Selective Partial Agonists

Synthesis and Biological Evaluation of Novel Hybrids of Highly Potent and Selective Α4β2-Nicotinic Acetylcholine Receptor (nachr) Partial Agonists.

Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines As Potent Α4β2 Nicotinic Acetylcholine Receptor Ligands

Neural Nachrs PET Imaging Probes

Synthesis and preclinical evaluation of <SUP>11</SUP>C-labeled (6-aryl-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors

Ligands for Brain Cholinergic Channel Receptors: Synthesis and in Vitro Characterization of Novel Isoxazoles and Isothiazoles As Bioisosteric Replacements for the Pyridine Ring in Nicotine

Biososteric Replacement in the Design and Synthesis of Ligands for Nicotinic Acetylcholine Receptors

Heteroaromatic and Aniline Derivatives of Piperidines As Potent Ligands for Vesicular Acetylcholine Transporter.

Pharmacological Characterization of [125I]CHIBA-1006 Binding, a New Radioligand for Α7 Nicotinic Acetylcholine Receptors, to Rat Brain Membranes

Identification Of Novel Alpha 4 Beta 2-Nicotinic Acetylcholine Receptor (Nachr) Agonists Based On An Isoxazole Ether Scaffold That Demonstrate Antidepressant-Like Activity

Recent Advances in PET Radioligands for Imaging of Cerebral Nicotinic Acetylcholine Receptors

Study on Chiba-1001 As A Novel Radioligand for Alpha 7 Nicotinic Acetylcholine Receptors

Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.

Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for α4β2 neuronal nicotinic acetylcholine receptors